OphthalmologyiNexin Eye Drops

iNexin eye drops is an innovative formulation of aCT1 developed to address unmet needs within the field of ophthalmology. Clinical development of iNexin eye drops is currently focused on corneal injuries with commercial and medical countermeasure applications. Existing treatments attempt to address the secondary symptoms of corneal injuries (e.g., irritation or itching), but iNexin has been developed to reset the injury response and promote regenerative healing. A first-in-human Phase 1 study is ongoing.

  • Ocular
    Injury/Disease
    Corneal Injury
  • Medical
    Counter-Measure
    Ocular Injury Induced by
    Chemical Warfare Agents
  • Pre-Clinical
  • Phase 1
  • Phase 2
  • Phase 3
  • NDA